Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17661
-
17662
-
17663
Expected changes in obesity after reformulation to reduce added sugars in beverages: A modeling study
Published 2018“…On average, 12.6% of the TEI was contributed by added sugars; we defined a 50% reduction in added sugars in SSBs over 10 years as a reformulation target. …”
-
17664
The efficacy of topical 8% capsaicin patches for the treatment of postsurgical neuropathic pain: a systematic review
Published 2024“…All studies that investigated neuropathic pain area denote a decrease in pain size, with some denoting a continued reduction with subsequent application.…”
-
17665
DataSheet_1_A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in health...
Published 2024“…</p>Methods<p>SB102 (NCT05408572) focused on safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) endpoints. SON-1010 at 50-300 ng/kg or placebo administered subcutaneously on day 1 was studied at a ratio of 6:2, starting with two sentinels; participants were followed through day 29. …”
-
17666
-
17667
-
17668
Created with BioRender.com.
Published 2024“…Thirteen patients had HFpEF (mean LVEF 55 ± 7%), and seven patients had HFrEF (mean LVEF 35 ± 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). …”
-
17669
Hyperbaric oxygen therapy details.
Published 2024“…Thirteen patients had HFpEF (mean LVEF 55 ± 7%), and seven patients had HFrEF (mean LVEF 35 ± 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). …”
-
17670
Triple immunofluorescence labeling comparing both sarcomeric actin and VDAC expression in control versus MFN2 mutant mice.
Published 2016“…Initially, note the selective expression of the mutant form of MFN2 in satellite cells of the mutant myofibers with occasion dissemination into the muscle fiber (white arrow-heads). Also note both the decreased intensity of sarcomeric actin immunolabelling in the mutant mice versus wild-type mice (compare A and B) and the relative disruption of striated myofibrillar distribution of VDAC positive mitochondria in mutant micrograph D versus C. …”
-
17671
Reduction of plasma membrane PtdIns(4)<i>P</i> and PtdIns(4,5)<i>P</i><sub>2</sub> levels and their effect on the Ins<i>P</i><sub>3</sub> and Ca<sup>2+</sup> signals upon hormonal...
Published 2015“…After hormonal stimulation (100 nM Ang II), 300 nM rapamycin was added manually to cause acute depletion of PtdIns(4,5)<i>P</i><sub><b>2</b></sub> in the PM. (means ± SE, n = 4). …”
-
17672
-
17673
-
17674
-
17675
-
17676
The impact of a CTL-based vaccine is dependent upon the extent to which it affects transmission potential.
Published 2011“…One vaccine (circles, A and B) considerably reduces transmission probability by a factor of 25 (), but restores life expectancy to its normal value (50 years; years<sup>−1</sup>). …”
-
17677
-
17678
UBKIs possess broad antiviral activity, are effective in primary cells, and impose a barrier against resistance development.
Published 2019“…The experiment was terminated after 8 passages. Data represent mean ± SD of technical replicates.</p>…”
-
17679
In-Car Nocturnal Blue Light Exposure Improves Motorway Driving: A Randomized Controlled Trial
Published 2012“…<div><p>Prolonged wakefulness greatly decreases nocturnal driving performance. The development of in-car countermeasures is a future challenge to prevent sleep-related accidents. …”
-
17680